SCHEMBL5201879

SCHEMBL5201879

Cc1c(/N=C2/NCCO2)cccc1NS(C)(=O)=O

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KEAP1 Q14145 2/20 0.46
NFE2L2 Q16236 1/20 0.46
GAA P10253 1/20 0.36
JAK2 O60674 1/20 0.36
JAK1 P23458 1/20 0.36
NR3C1 P04150 4/20 0.36
PGR P06401 2/20 0.36
NR3C2 P08235 2/20 0.36
AR P10275 2/20 0.36
ADRA1A P35348 2/20 0.36
GLO1 Q04760 2/20 0.35
ALOX15 P16050 1/20 0.35
HTT P42858 1/20 0.35
KMT2A Q03164 2/20 0.34
NPC1 O15118 1/20 0.34
RAB9A P51151 1/20 0.34
ALDH1A1 P00352 1/20 0.34
TP53 P04637 1/20 0.34
ADRA2A P08913 1/20 0.33
MEN1 O00255 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5201883 1.00 KEAP1 (0.46) KEAP1NFE2L2GAAJAK2JAK1
SCHEMBL5203045 0.80 KEAP1 (0.51) KEAP1NFE2L2GAAJAK2JAK1
SCHEMBL12990378 0.65 KEAP1 (0.67) KEAP1NFE2L2NR3C1PGRNR3C2
SCHEMBL15108064 0.65 KEAP1 (1.00) KEAP1NFE2L2JAK2JAK1NR3C1
SCHEMBL13869170 0.64 KEAP1 (0.65) KEAP1NFE2L2NR3C1PGRNR3C2
SCHEMBL11685491 0.62 MAPT (0.42) GAAHTTKMT2ANPC1RAB9A
SCHEMBL5205970 0.62 NR3C1 (0.40) KEAP1NFE2L2GAANR3C1PGR
SCHEMBL3962709 0.62 KEAP1 (0.67) KEAP1NFE2L2JAK2JAK1NR3C1
SCHEMBL5965425 0.62 KEAP1 (0.67) KEAP1NFE2L2GAANR3C1PGR
SCHEMBL1335286 0.62 KEAP1 (0.67) KEAP1NFE2L2JAK2JAK1NR3C1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0887346-B1 N-Phenyl-alkylsulfonamide derivatives, their preparation and their use as alpha1A/1L adrenoceptor agonists HOFFMANN LA ROCHE (CH) 2007-12-12 EP disclosed
US-6057349-A ALPHA.SUB.1A/1L AGONISTS USED IN THE TREATMENT OF VARIOUS DISEASE STATES SUCH AS URINARY INCONTINENCE, NASAL CONGESTION, PRIAPISM, DEPRESSION, ANXIETY, DEMENTIA, SENILITY, ALZHEIMER'S, DEFICIENCIES IN ATTENTIVENESS AND COGNITION, AND F. HOFFMAN LA ROCHE AG (CH) 2000-05-02 US disclosed
EP-0887346-A2 Phenyl-and aminophenyl-alkylsulfonamide and urea derivatives, their preparation and their use as alpha1A/1L adrenoceptor agonists F. HOFFMANN-LA ROCHE AG (CH) 1998-12-30 EP disclosed